Page last updated: 2024-11-04

tungstic(vi) acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tungstic(VI) acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1152
CHEBI ID36272
MeSH IDM0075572

Synonyms (36)

Synonym
dihydroxidodioxidotungsten
CHEBI:36272 ,
dihydrogen wolframate
h2wo4
[wo2(oh)2]
tungstic(vi) acid
tungstate (wo42-), dihydrogen, (t-4)-
einecs 231-975-2
j4d6k0rx2g ,
unii-j4d6k0rx2g
tungstate (wo42-), dihydrogen, (beta-4)-
tungstic acid (h2wo4)
ec 231-975-2
tungstate (wo42-), hydrogen (1:2), (t-4)-
tunstic acid
tungstic acid
dihydroxy(dioxo)tungsten
NCI60_009849
7783-03-1
tungsten hydroxide oxide
tungstic acid, 99.999% trace metals basis
tungstic acid, 99%
tungstic acid, >=99.0% (calcined substance, t), powder
AKOS015960973
C20679
tungstic(vi) acid [mi]
wolframic acid, anhydrous
CMPGARWFYBADJI-UHFFFAOYSA-L
J-525145
pyrrolidine, 1-(2,6-dimethylphenyl)-
mfcd00011336
wolframsaure
Q416538
tungstic acid, 99.95% metals basis
SB66399
PD162531
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tungsten coordination entity
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (56.10)18.7374
1990's3 (7.32)18.2507
2000's8 (19.51)29.6817
2010's7 (17.07)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.80 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]